Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02376361 · ClinicalTrials.gov registry record · NA
Hemodialysis Access Surveillance Evaluation Study
A NA study, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 436
- Enrollment target
NCT02376361: Completed NA study, sponsored by Albany Medical College.
NCT02376361 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 436 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02376361, a NA study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
Study Summary
The purpose of the study is to learn if monitoring dialysis access blood flow during dialysis treatment with a transonic machine (an ultrasound technique) will prevent (or reduce) the development of dialysis access thrombosis (clotting). Investigators would like to study if monitoring with a specific technique called ultrasound dilution technique can help prevent problems with access when compared to what is the current standard of care for patients.
Primary Outcome
Evaluate the reduction of hemodialysis access thrombosis rate
Interventions
- DEVICE Transonic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2015-03 |
| Est. Completion | 2019-07 |
| Phase | NA |
What the finished NCT02376361 record still lists
NCT02376361 is an interventional study that assigns participants to a tested intervention. The registered 436 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Transonic is the first listed.
NCT02376361 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02376361 about?
NCT02376361 is a clinical study titled "Hemodialysis Access Surveillance Evaluation Study". The purpose of the study is to learn if monitoring dialysis access blood flow during dialysis treatment with a transonic machine (an ultrasound technique) will prevent (or reduce) the development of dialysis access thrombosis (clotting). Investigators would like to study if monitoring with a specif...
What is the current status of trial NCT02376361?
This trial is currently completed. It is a NA study. The enrollment target is 436 participants. The study started on 2015-03. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02376361?
The interventions under investigation include: Transonic (DEVICE).
Who is sponsoring clinical trial NCT02376361?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02376361's enrollment target sits among peer trials
436 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- NCT07318493 · 436 participants · NA
Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia